Treating Neuroendocrine Prostate Cancer
This presentation reviews the biology, diagnosis, and treatment of neuroendocrine prostate cancer, an aggressive and evolving disease state.
Read More
Select Page
Oscar B. Goodman Jr., MD, PhD, is a physician-scientist and genitourinary oncologist who has been practicing as a hematologist, medical oncologist, and clinical researcher in Las Vegas since 2007, joining Nevada Oncology Specialists in early 2025. He participates in basic, translational, and clinical research studies. His translational research interests center on understanding the mechanisms that govern prostate cancer’s therapeutic resistance. He has authored numerous abstracts, book chapters, and more than 50 peer-reviewed publications. He has also received peer-reviewed prostate cancer research support through the Department of Defense.
Dr. Goodman completed his undergraduate studies at Swarthmore College in Pennsylvania, earned his medical degree at Jefferson Medical College, and received his PhD at Thomas Jefferson University, both in Philadelphia. Dr. Goodman completed his internship and residency in internal medicine, as well as fellowships in hematology and medical oncology, at NewYork-Presbyterian Hospital, Weill Cornell Campus, in New York City. He later worked as a clinical associate and then as an assistant professor in the Department of Medicine, Division of Hematology/Oncology, at NewYork-Presbyterian Hospital, Weill Cornell Campus.
Dr. Goodman is a recipient of the Young Investigator Award from the American Society of Clinical Oncology and has been named a Regional Top Doctor by US News & World Report and Castle-Connolly annually since 2008. He has been honored as a Research Healthcare Headliner by Vegas Inc. and received the 2014 Southern Nevada Technology & Research Healthcare Hero Award from Nevada Business Magazine. He was also awarded the Inspired Excellence in Health Care Award by Las Vegas HEALS. In addition, he has been consistently recognized as a Top Doctor by Vegas Inc. and Desert Companion in their annual polls.
Oscar B. Goodman, Jr., MD, PhD | Apr 2026
This presentation reviews the biology, diagnosis, and treatment of neuroendocrine prostate cancer, an aggressive and evolving disease state.
Read More